On June 18, the World Health Organization said that in the event of an effective vaccine against the new coronavirus, countries should cooperate in large-scale production,media reported. Soumya Swaminathan, WHO’s chief scientist, told an online press conference that about 300 vaccines are currently in the experimental stage, three of which are about to enter the final human clinical trial.
If the trial is successful, one or more vaccines in numbers of hundreds of millions of doses will be available by the end of this year and are expected to increase to billions next year.
To achieve this, countries need to support and invest in the CoVID-19 Vaccine Global Access Facility, says Suma Swamynathan.
“We can only do this if the world works together to reach a consensus on this mechanism,” said Suma Swamynathan. We are therefore proposing the establishment of a framework to determine who should be given priority vaccination. For example, some groups of front-line workers, drivers and ambulance workers, as well as other health workers, as well as police officers, retail store clerks, cleaners, can be exposed to a large number of viruses. “
Other high-risk groups that may benefit from the vaccine include the elderly and people with high blood pressure, diabetes and dementia, says Suma Swamynathan. People in prisons, sanatoriums, factories and urban slums that have already experienced outbreaks should also be given priority vaccination.